Boston Tech
Julia Grew Up at MIT and Now Wants to Build the Plane Too
MIT-born Julia now serves over one million users and powers JuliaHub’s physics-aware Dyad tools, a serious Boston bet on engineering software.
Boston Tech
MIT-born Julia now serves over one million users and powers JuliaHub’s physics-aware Dyad tools, a serious Boston bet on engineering software.
Boston Tech
Liquid AI’s Pipette benchmarks on-device AI across models, quantization, runtimes, and real hardware, making edge performance easier to inspect.
Boston Tech
Massachusetts opened $500,000-to-$2 million grants for climate-tech and life-sciences facilities, betting the next breakthrough needs actual machinery.
Boston Tech
Cambridge startup Apollo Atomics raised $31 million to build compact, factory-made nuclear reactors around a radically smaller steam generator.
Boston Tech
Moderna and Merck say their personalized mRNA cancer vaccine met Phase 3 melanoma endpoints. The Cambridge biotech has a real win, with caveats.
Boston Tech
Cambridge venture firm Floating Point is targeting a $120 million third fund for complex startups in healthcare, energy, logistics, and defense.
Boston Tech
Cambridge AI music company Suno partnered with BMG on a new industry-developed model, turning copyright pressure into a serious licensing bet.
Boston Tech
Burlington’s Azenta grew 12% in Q3 as biotech demand lifted sample management and multiomics, but quality costs keep the turnaround honest.
Boston Tech
MacPaw is partnering with Cambridge’s Liquid AI to bring on-device inference to developers building AI-powered Mac apps for Setapp.
Boston Tech
Salem is replacing Flock license-plate readers with city-owned cameras, forcing Massachusetts to confront who owns public-safety data and public trust.
Boston Tech
Massachusetts lawmakers passed a $575.4 million package pairing AI safety rules with robotics funding and research support. The hard part is implementation.
Boston Tech
Mass General won up to $25.8 million from ARPA-H to build a reusable gene-editing platform for rare vascular diseases in Boston and beyond for patients.